نتایج جستجو برای: graft disparity

تعداد نتایج: 99853  

Journal: :Transplantation proceedings 2000
C Anasetti E W Petersdorf P J Martin A Woolfrey J A Hansen

Transplantation of hematopoietic stem cells from human leukocyte antigen (HLA)-compatible unrelated volunteer donors have become feasible for more than 70% of patients without a family match. Chronic myeloid leukemia is the most common indication for unrelated donor marrow transplantation. The 5year survival for patients up the age of 50 years has improved to 75% with transplantation in the chr...

Journal: :The Tohoku journal of experimental medicine 2008
Toshihiko Ando Toshiaki Yujiri Jun Nomiyama Noriyuki Mitani Masato Seguchi Atsushi Matsubara Yukio Tanizawa

In allogeneic stem cell transplantation, immune reactions can occur in 2 directions. The recipient's lymphocytes can recognize the donor's cells as "foreign" and attempt to kill them, which results in the host-versus-graft (HVG) reaction that is commonly termed graft rejection. The other direction is the graft-versus-host (GVH) reaction. When the recipient is homozygous at a mismatched human le...

2017
Giuseppina Li Pira Stefano Di Cecca Simone Biagini Elia Girolami Elisabetta Cicchetti Valentina Bertaina Concetta Quintarelli Ignazio Caruana Barbarella Lucarelli Pietro Merli Daria Pagliara Letizia Pomponia Brescia Alice Bertaina Mauro Montanari Franco Locatelli

Hematopoietic stem cell transplantation is standard therapy for numerous hematological diseases. The use of haploidentical donors, sharing half of the HLA alleles with the recipient, has facilitated the use of this procedure as patients can rely on availability of a haploidentical donor within their family. Since HLA disparity increases the risk of graft-versus-host disease, T-cell depletion ha...

Journal: :Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016
Robert Chiesa Annalisa Ruggeri Annalisa Paviglianiti Marco Zecca Marta Gónzalez-Vicent Victoria Bordon Jerry Stein Sarah Lawson Sophie Dupont Edoardo Lanino Manuel Abecasis Amal Al-Seraihy Chantal Kenzey Marc Bierings Franco Locatelli Eliane Gluckman Ansgar Schulz Andrew Gennery Kristin Page Joanne Kurtzberg Vanderson Rocha

Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for most children with osteopetrosis (OP). Timing of HSCT is critical; therefore, umbilical cord blood transplantation (UCBT) is an attractive option. We analyzed outcomes after UCBT in 51 OP children. Median age at UCBT was 6 months. Seventy-seven percent of the cord blood grafts had 0 or 1 HLA disparity with the rec...

Journal: :American journal of physiology. Heart and circulatory physiology 2004
Zhihua Jiang Lizhen Wu Brett L Miller Darin R Goldman Chessy M Fernandez Zaher S Abouhamze C Keith Ozaki Scott A Berceli

Accelerated intimal hyperplasia in response to altered flow environment is critical to the process of vein bypass graft failure. Lack of a reproducible animal model for dissecting the mechanisms of vein graft (VG) remodeling has limited progress toward solving this clinically significant problem. Combining a cuffed anastomotic technique with other surgical manipulations, we developed a well-def...

Journal: :International journal of ophthalmology 2014
Jin A Choi Min A Lee Man-Soo Kim

AIM To investigate the long-term results of penetrating keratoplasty (PK) in patients with keratoconus (KC) and to evaluate factors that might influence the final visual outcome. METHODS We retrospectively reviewed the data of all patients with clinical KC who had undergone PK by a single corneal surgeon in a single center from May 1980 to December 2005. The age of the patients, preoperative ...

Journal: :Haematologica 2016
Yasuyuki Arai Tadakazu Kondo Hirohito Yamazaki Katsuto Takenaka Junichi Sugita Takeshi Kobayashi Yukiyasu Ozawa Naoyuki Uchida Koji Iwato Naoki Kobayashi Yoshiyuki Takahashi Ken Ishiyama Takahiro Fukuda Tatsuo Ichinohe Yoshiko Atsuta Takehiko Mori Takanori Teshima

Allogeneic bone marrow transplantation is an essential therapy for acquired aplastic anemia and prognosis has recently improved. However, engraftment failure and graft-versus-host disease are potential fatal complications. Various risk factors for poor prognosis have been identified, such as patient age and human-leukocyte antigen disparity, but the relationship between donor age and prognosis ...

Journal: :Blood 1996
J E Wagner J Rosenthal R Sweetman X O Shu S M Davies N K Ramsay P B McGlave L Sender M S Cairo

To reduce the morbidity and mortality associated with unrelated donor bone marrow (BM) transplantation and potentially extend the pool of suitable donors, cryopreserved unrelated donor umbilical cord blood was considered as an alternate source of hematopoietic stem cells for transplantation. Patients with leukemia, BM failure syndrome, or inborn error of metabolism were eligible for a phase I c...

Journal: :Hematology. American Society of Hematology. Education Program 2010
Mary Eapen Mary M Horowitz

Patients with severe aplastic anemia who do not have a human leukocyte antigen (HLA)-identical sibling generally receive immunosuppressive therapy as a first-line therapy, with allogeneic transplantation being reserved for those who do not have an adequate sustained response. Barriers to the use of unrelated-donor transplantation for aplastic anemia include identifying a suitable alternative do...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید